Sally Webb is Marketing Programs Manager, LC/MS-Proteomics/Metabolomics and is with Agilent Technologies, Santa Clara, California.
Mass Spectrometry for Metabolomics: Addressing the Challenges
July 1st 2007Metabolomics is a developing analytical approach that is growing rapidly in importance as a tool to improve diagnosis and treatment of disease, as well as to speed up the drug development process. Unlike genomics or proteomics, which only reveal part of what might be happening in a cell, metabolomic profiling can give an instantaneous snapshot of the entire physiology of that cell. This article describes the challenges associated with metabolomics research and new tools developed to overcome them.